Comparison of Methods for The Purification of Goat Lactoferrin and Antiviral Activity to Human Papillomavirus

Anggraeni R. Yugis¹, Agus Saputra¹, Rachmitasari Noviana², Diah Iskandriati², Joko Pamungkas^{2, 3} and Irma H. Suparto^{1, 2,}

¹Department of Chemistry, Faculty Mathematic and Science, Bogor Agricultural University, Bogor-West Java, Indonesia

²Primate Research Centre, Bogor Agricultural University, Bogor-West Java, Indonesia

³Faculty of Veterinary Medicine, Bogor Agricultural University, Bogor-West Java, Indonesia

Cite this paper:
Anggraeni R. Yugis, Agus Saputra, Rachmitasari Noviana, Diah Iskandriati, Joko Pamungkas and Irma H. Suparto. Comparison of Methods for The Purification of Goat Lactoferrin and Antiviral Activity to Human Papillomavirus. American Journal of Microbiological Research. 2015; 3(5):171-175. doi: 10.12691/ajmr-3-5-4

Abstract

Lactoferrin (Lf) has been reported for its multifunctional properties such as antifungal, antibacterial, antiviral, antioxidant and anticancer activities. This protein is an 80 kDa iron-binding protein of the transferrin family. It can be isolated from milk and has been identified from various mammalian secretions. The aims of this study focused on the isolation and purification of Lf from etawa goat colostrum using several methods of chromatography and observing its activities as antiviral human papillomavirus (HPV). Purification was performed by gel filtration chromatography using Sephadex G-75 and G-100, for cation exchange chromatography with carboxymethyl Sephadex C-50, and two-steps chromatography of cation exchange resin carboxymethyl Sephadex C-50 and gel filtration resin Sephadex G-75. All columns were prepared by manual packaging. The native isolated Lf was characterized by SDS-PAGE electrophoresis. Our result showed that the best purified goat lactoferrin (gLf) was by two-steps chromatography with yield of 364 μg/mL and molecular weight 82 kDa. The pure gLf showed anti-HPV effect at concentration of 100 μg/mL after 72 hours incubation by the increased in cycle threshold (Ct) value, from 26 Ct to 36 Ct.

Keywords:
goat lactoferrin purification ion exchange chromatography gel filtration chromatography anti-human papillomavirus

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Abdel-Salam, A., Alhabri, K.B., Magzoub, M.A. and Mousa, H.M, “Effect of heat treatment on the chromatographic detection, electrophoretic pattern and antimocrobial activity purified from camel milk,”J Food Agri Environ, 12 (2). 20-23. April.2014.
[2]	Adam, S., Zitka, O., Dolezal, P., Zeman, L., Horma, A., Hubalek, J., Sileny, J., Krizkova, S., Trnkova L. and Kizek, R, “Lactoferrin isolation using monolithic column coupled with spectrometric or micro-amperometric detector,” Sensors, 8. 464-487. January.2008.
[3]	Adlerova, L., Bartoskova, A. and Faldyna, M, “Lactoferrin: A review,” Vet Med, 53(9). 457-468. January.2008.
[4]	Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A. and Valenti, P. “Antiviral properties of lactoferrin-a natural immunity molecule,” Molecules, 16. 6992-7018. Aaugust.2011.
[5]	Bezault, J., Bhimani, R., Wiprovnick, J. and Furmanski, P, “Human lactoferrin inhibits growth of solid tumors and development of experimental metastates in mice,” Cancer Res. 54. 2310-2312. March.1994.
[6]	Campanella, L., Martini, E., Pintore, M. and Tomassetti, M, “Determination of lactoferiin and immunoglobulin G in animalnmilky by New Immunosensors,” Sensors 9. 2202-2221. March.2009.
[7]	Chaves, S.A.G., Gallegos, S.A. and Cruz, Q, “Lactoferrin: structure, function and application,” Int. J. Antimicrob. Agents 33. 301Le1-301Le8. 2009.
[8]	Chen, H.L., Wang, L.C., Chang, C.H., Yen, C.C., Cheng, W.T.K., Wu, S.C., Hung, C.M., Kuo, M.F. and Chen, C.M, “Recombinant porcine lactoferrin express in the milk of transgenic mice protect neonatal mice from a lethal challange with enterovirus type 71,” Vaccine 26. 891-898. January.2008.
[9]	Chien, Y.J., Chen, W.J., Hsu, W.L. and Chiou, S.S, “Bovine lactoferrin inhibits Japanese enchephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein,” Virol. 379. 143-151. July.2008.
[10]	Conesa, C., Sanchez, L., Rota, C., Perez, M.D., Calvo, M., Farnaud, S. and Evans, R.W, “Isolation of lactoferrin from milk different species: calorimetric and antimicrobial studies,” Comp. Biochem. Physiol. Part B 150. 131-139. February.2008.
[11]	Davoodi, H., Esmaeili, S. and Mortazavian, A.M, ‘Effect of milk and milk products consumption on cancer: a review,” Comp. Review Food Sci. Food Safety 12. 249-264. December.2012.
[12]	Drackova, M., Borkovcova, I., Janstova, B., Naiserova, M., Pridalova, H., Navratilova, P. and Vorlova, L, “Determination of lactoferrin in goat milk by HPLC method,” Czech J. Food Sci. 27. S102- S104. 2009.
[13]	Ebringer, L., Ferencik, M. and Krajovic, J, “Beneficial health effect of milk and fermented dairy products-Review,” Folia Microbiol. 53 (5). 378-394.April.2008.
[14]	Elagamy, E.I., Ruppanner, R., Ismail, A., Champagne, C.P. and Asaaf, R, “Purification and characterization of lactoferrin, lactoperoxidase, lysozym and immunoglobulins from Camel’s milk,” Int. Dairy J. 6.129-145. November.1994.
[15]	El-Fakharany, E.M., Abedelbaky, N., Haroun, B.M., Sanchez, L., Redwan, N.A. and Redwan, E.M, “Anti-infectivity of camel polyclonal antibodies againts hepatitis C virus in Huh&.5 hepatoma,” J. Virol. 9 (201). 1-9. 2012.
[16]	El-Fakharany, E.M., Sanchez, L., Al-Mehdar, H.A. and Redwan, E.M, “Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparasion study,” J. Virol. 10(199). 1-10. 2013.
[17]	El-Hatmi, H., Levieux, A. and Levieux, D, “Camel (Camelus dromedarius) immunoglobulin G, α-lactabumin, serum albumin and lactoferrin in colostrum and milk during early postpartum period,” J .Dairy Res. 73. 288-293. 2006.
[18]	El-Loly, M.M. and Mahfouz, M.B, “Lactoferrin in relation to biological functions and applications: a review,” Int. J. Dairy Sci. 6(2). 79-111. 2011.
[19]	Florin, P.E., Moisei, M., Trif, M., Evans, R.W. and Roseanu, A, “Anti-inflamatory and anti-tumor activity of human recombinant lactoferrin,” Rom. J. Biochem. 49(2). 163-171. October.2012.
[20]	Fujita, K., Matsuda, E., Sekine, K., Iigo, M. and Tsuda, H, “Lactoferrin enhances fas expression and apoptosis in the colon mucosa of azoxymethane-trated rats,” Carcinogenic. 25 (10). 1961-1966. 2004.
[21]	Groot, F., Geijtenbeek, T.B.H., Sanders, R.W., Baldwin, C.E., Sanches-Hernandez, M., Floris, R., van Kooyk, Y., de Jong, E.C. and Barkhout, B, “Lactoferrin prevents Dendritic Cell-mediated human immunodeviciency virus type 1 transmission by blocking the DC_SIGN-gp120 interaction,” J. Virol. 79(5). 3009-3015. March.2005
[22]	Hodgikson, A.J., Ross, K.M., Fahey, S.N. and Prosser, C.G, “Quantification of lactoferrin in milk from New Zealand dairy goats,” in Proceedings of the New Zealand Society of Animal Production. 68. 166-169.
[23]	Hoek, K.S., Milne, J.M., Grieve, P.A., Dionysius, D.A. and Smith, R, “Antibacterial activity of bovine lactoferrin-derivated peptides,” Antimicrob. Agents and Chemotheraphy. 41(1). 54-59. January.1997.
[24]	Indyk, H.E. and Filonzi, E.L, “Determination of lactoferrin in bovine milk, colostrum and infant formulas by optical biosensor analysis,” Int. Dairy J. 15. 429-438. September.2004.
[25]	Kobayashi, T., Kakeya, H., Miyazaki, T., Izumakiwa, K., Yanagahira, K., Ohno, H., Yamamoto, Y., Tashiro, T. and Kohno, S, “Synergistic antifungal effect of lactoferrin with azole antifungals againts Candida albicans for invasive candidiasis,” Jpn. J. Infect. Dis. 64: 292-296. April.2011.
[26]	Le Parc, A., Dallas, D.C., Duant, S., Leonil, J., Martin, P. and Barile, D, “Characterization of goat milk lactoferrin N-glycans and comparation with the N-glycomes of human and bovine milk,” Electrophoresis. 35 (11). 1560-1570. June.2014.
[27]	Levay, P.F. and Viljoen, M, “Lactoferrin: a general revie,” Haematologica (80). 252-267. March.1995.
[28]	Lupetti, A., Brouwer, C.P.J.M., Bogaards, S.J.P., Welling, M.M., de Heer, E., Campa, M., van Dissel, J.T., Friesen, R.H.E., Nibbering, P.H, “Human lactoferrin-derived peptide’s antifungal activitiess againts disseminated Candida albicans infections” J. Infection Disease. 196. 1416-1424October.2007.
[29]	Mistry, N., Drobni, P., Naslund, J., Sunkari, V.G., Jenssen, H. and Evander, M, “The anti-papillomavirus activity of human and bovine lactoferrin,” Antivir. Res. (75). 258-265. March.2007.
[30]	Moradian, F., Sharbafi, R. and Rafiei, A, “Lactoferrin, isolation, purification and antimicrobial effect,” J. Med. Bioengine. 3 (3). 1-4. September.2014.
[31]	Nam, M.S., Shimazaki, K., Kumara, H., Lee, K.K. and Yu, D.Y, “Characterization of Korean native goat lactoferrin,” Comparative Biochem. And Physio. Part B. 123. 201-208. March.1999.
[32]	Neville, M.C. and Zhang, P, “Lactoferrin secretion into milk: Comparation between ruminant, murine and human milk,” J. Anim. Sci.78. 26-35.2000.
[33]	Oztas, Y.E. and Ozgunes, N, “Lactoferrin: a multifunctional proteins,” Int. J. Mol. Biol. Biochem. Gene Technol. 1(4). 149-154. December.2005.
[34]	Pellegrini, A. and Engels, M, “Antiviral compounds derived from naturally occurring proteins,” Curr. Med. Chem. 4. 55-66. 2005.
[35]	Pietrantoni, A., Biase, A.M.D., Tinari, A., Marchetti, M., Valenti, P., Seganti L. and Superti, F, “Bovine lactoferrin inhibits adenovirus infectio by interacting with viral structural polypeptides,” Antimicrob. Agents Chemo. 47(8). 2688-2691. August.2003.
[36]	Potocnik, K., Ganter, V., Kuterovac, K. and Cividini, A, “Mare’s milk: composition and protein fraction in comparison with different milk species,” Mljekarstvo. 61 (2). 107-113. May.2011.
[37]	Steijns, J.M. and van Hooijdonk, A.C.M, “Occurence, structure, biochemical properties and technological characteristics of lactoferrin,” Brit. J. Nut. 84 (suppl.1). S11-S17. 2000.
[38]	Strate, B.W.A., Beljaars, L., Molema, G., Harmsen, M.C. and Meijer, D.K.F, “Antiviral activities of Lactoferrin,” Antiviral Reserch 52. 225-239. September.2001.
[39]	Takakura, N., Wakabayashi, H., Ishibashi, H., Yamamuchi, K., Teraguchi, S., Tamura, Y., Yamaguchi, H. and Abe, S, “Effect of orally administrated bovine lactoferri on the immune response in the oral candidiasis murine model,” J. Med. Microbiol. 54. 495-500. January.2004.
[40]	Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S. and Sekihara, H, “Lactoferrin inhibits Hepatitis C Virus viremia in patiens with chronic hepatitis C: a pilot study,” Jpn. J. Cancer Res. 90. 367-371. April.1999.
[41]	Tuccari, G., Villari, D., Giuffre, G., Simone, A., Squadrito, G., Raimondo, G. and Barresi, G, “Immunohistochemical evidence of lactoferrin in hepatic biospesies of patiens with viral or cryptogenetic chronic liver disease,” Histol. Histopathol. 17. 1077-1083. 2002.
[42]	World Health Organition, Comperehensive cervical cancer prevention and control: a helthier future for girls and women, WHO Guidance Note, 2013 [E-book] Available:
[43]	Wu, M. and Xu, Y, “Isolation and purification of lactoferrrin and immunoglobulin G from bovine colostrum with serial cation-anion exchange chromatography,” Biotech. Biopro. Eng. 144.155-160. 2009.
[44]	Wu, M., Wang, X., Zhang, Z. and Wang R, Isolation and purification of bioactive proteins from bovine colostrum, Progress in Molecular and Enviromental bioengineering - From Analysis and Modeling to Technology Application, 2011. [E-book] Available:http://www.intechpone.com/books/progress-in-molecular-and-enviromental-bioengineering-from-analysis-and-modeling-to-technology-applications/isolation-and-purification-of-bioactive-proteins-from-bovine-colostrum.
[45]	Wu, W.Z., Wang, X.Q., Wu, G.Y., Kim, S.W., Chen, F. and Wang, J.J, “Differential composition of proteonomes in sow colostrum and milk from anterior and posterior mammary glands,” J. Anim. Sci. 88. 2657-2664. April.2010.
[46]	Yamada, Y., Sato, R., Kobayashi, S., Hankanga, C., Inanami, O., Kuwabara, M., Momota, Y., Tomizawa, N. and Yasuda, J. “The antiproliferative effect of bovine lactoferrin on canine mammary gland tumor cell,” J. Vet. Med. Sci. 70(5). 443-448. December.2007.
[47]	Zuccoti, G.V., Salvini, F., Riva, E. and Agostini, C, “Oral lactoferrinn in HIV-1 vertically infected children; an observational follow-up of plasma viral load and immune system,” J. Int. Med. Res. 34. 88-94. 2006.